Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Datroway
Pharma
AZ's $80B revenue target 'very much within reach,' CFO says
AZ's oncology chief suggested the PD-L1 inhibitor Imfinzi will likely be the company's largest oncology medicine by sales “in the midterm period.”
Angus Liu
Jan 14, 2026 10:00am
Merck partner Kelun touts ph. 3 win for ADC in first-line NSCLC
Nov 24, 2025 10:56am
Merck grows more ambitious about 'workhorse' TROP2 ADC
Oct 20, 2025 4:00pm
ESMO: Datroway data edge out Trodelvy in first TROP2 face-off
Oct 19, 2025 2:30am
TROP2 showdown, InnoCare-Zenas, Lupin—Fierce Pharma Asia
Oct 10, 2025 10:55am
AZ, Daiichi's Datroway scores overall survival win in TNBC
Oct 6, 2025 10:48am
